Drugs / DLBS1449
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01972477 | Jul 2016 → Oct 2017 | hypoalphalipoproteinemia | Dexa Medica Group | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DLBS1449 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01972477 ↗ |